Require the Pentagon to provide Congress with a comprehensive assessment of emerging clinical research and service-related treatments for PTSD for veterans and servicemembers.

Abraham J. Hamadeh · Arizona · Republican

oversight impact 0.46 specificity 0.86 extraction confidence 88%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

The legislation, which directs the Pentagon to provide Congress with a comprehensive assessment of emerging clinical research and service-related treatments for PTSD

Hamadeh's press release says his Veterans and Servicemembers PTSD Emerging Treatment Review Act would direct the Pentagon to assess emerging PTSD research and treatments for Congress.

Congressman Hamadeh Introduces Legislation to Advance Research on Emerging PTSD Treatments for Veterans and Servicemembers
primary · press_release · model gpt-5.5

Evidence

unverified · Source version 64782 · locator unknown

The House Armed Services Committee report includes an item titled “Assessment of Emerging Clinical Research for Treatment-Resistant PTSD” and directs the Secretary of Defense to provide a report to the House Committee on Armed Services by February 1, 2027 assessing Phase I Passage and Phase II Fortitude Trial data and its potential applicability to active-duty, reserve, and transitioning servicemembers, including safety, dosing, adverse event data, readiness, suicide prevention, legal/regulatory pathways, and pilot timelines.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): This is a concrete committee-report directive for a Pentagon assessment on emerging PTSD treatment research, closely matching the commitment, but it is not yet evidence that the report has been delivered or that a statutory requirement has been enacted.

partial same_term A for effort

CRPT-119hrpt698.pdf
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

GovInfo lists H.R. 9547 as introduced in the House on June 30, 2026 by Abraham J. Hamadeh of Arizona and referred to the House Committee on Armed Services. The bill’s full title is to direct the Secretary of Defense to submit to Congress a report on emerging investigational treatment options for treatment-resistant PTSD in veterans, members of the Armed Forces, and members transitioning to civilian life.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Hamadeh introduced standalone legislation that would create the requested Pentagon-to-Congress reporting requirement, but the official record shown here reflects introduction/referral rather than enactment or a completed report.

partial same_term A for effort

H.R. 9547 (IH) - Veterans and Servicemembers PTSD Emerging Treatment Review Act of 2026
secondary · model gpt-5.5 · confidence 88%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): partial. same_term A for effort

Hamadeh materially advanced the promised Pentagon-to-Congress PTSD treatment assessment during his same federal term by introducing H.R. 9547 and by securing or supporting closely matching committee-report language directing the Defense Department to provide a detailed assessment by February 1, 2027. However, the evidence shows referral and a committee directive, not enacted statutory language or a completed Pentagon report. Because the promised outcome has not yet been fully delivered, partial credit is appropriate rather than delivered.

provider codex_cli · model gpt-5.5 · confidence 88%